title: Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway.
abstract: OBJECTIVE
  To prospectively study the relation between TSH and risk of hip and forearm fractures.
  
  
  METHODS
  A population-based cohort study.
  
  
  METHODS
  In a substudy of the second survey of the Nord Trøndelag Health Study, Norway (HUNT2, 1995-97), linked with a hospital-based fracture registry, we investigated the relation between baseline TSH and risk of hip and/or forearm fractures.
  
  
  METHODS
  A total of 16 610 women and 8595 men aged 40 years or more, without previous self-reported thyroid disease and hip or forearm fractures.
  
  
  RESULTS
  During 12.5 years follow-up, a total of 1870 women and 342 men experienced hip or forearm fractures. Overall, there was no relation between baseline TSH and fracture risk. However, there was weak evidence that women with TSH <0.5 and >3.5 mU/l had a slightly increased risk of hip fractures (hazard ratio (HR) 1.30, 95% CI 0.97-1.94 and HR 1.19, 95% CI 0.93-1.52) compared with the reference group with TSH of 1.5-2.4 mU/l. Supplementary analyses showed higher hip fracture risk in women with TSH >4.0 mU/l and negative thyroid peroxidase antibodies (TPOAb) compared with the reference group (HR 1.75, 95% CI 1.24-2.46).
  
  
  CONCLUSIONS
  We found no statistically significant relation between baseline TSH and subsequent fracture risk, but the data suggest a weak positive association with hip fracture risk among women with both low and high TSH. The latter association was confined to women with negative TPOAb status.
authors.affiliation: Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.
authors.forename: Anders
authors.initials: A
authors.lastname: Svare
authors.forename: Tom Ivar Lund
authors.initials: TI
authors.lastname: Nilsen
authors.forename: Bjørn Olav
authors.initials: BO
authors.lastname: Asvold
authors.forename: Siri
authors.initials: S
authors.lastname: Forsmo
authors.forename: Berit
authors.initials: B
authors.lastname: Schei
authors.forename: Trine
authors.initials: T
authors.lastname: Bjøro
authors.forename: Arnulf
authors.initials: A
authors.lastname: Langhammer
mesh_terms: D000328:Adult; D000368:Aged; D015519:Bone Density; D005260:Female; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000097:blood* / Q000453:epidemiology* / Q000209:etiology / Q000378:metabolism; D006620:Hip Fractures / Q000097:blood / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D016017:Odds Ratio; D011446:Prospective Studies; D011885:Radius Fractures / Q000097:blood / Q000453:epidemiology; D012042:Registries; D012306:Risk; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000378:metabolism*; D013972:Thyrotropin / Q000097:blood*; D014458:Ulna Fractures / Q000097:blood / Q000453:epidemiology
chemical_list: D013972:Thyrotropin